GL1X · GenesisL1 explorer

Ligand · 4EL

4EL · 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid

4EL, 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid (C23 H21 N5 O5 S2, 511.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
4EL
Formula
C23 H21 N5 O5 S2
Class
ligand
Structures
2
PDB entries
1

Binding sites

4EL in 2 structures; the first of them:

  • 4YKN · Pi3K alpha lipid kinase with Active Site Inhibitor · 4EL A2101 · binds ARG1770, MET1772, SER1774, LYS1776, PRO1778, TRP1780, ILE1800, LYS1802 and 12 more
  • 4YKN · PI3K alpha lipid kinase with active site inhibitor · 4EL A2101 · binds ARG1770, MET1772, SER1774, LYS1776, PRO1778, TRP1780, ILE1800, LYS1802 and 12 more

Residues it binds most

TRP 6, VAL 6, ARG 6, ILE 4, SER 4, TYR 6, ASN 4, GLU 4, HIS 4, LYS 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.